Health News : [body]

Yahoo! Health - My Alerts - Edit Alert

Thursday, Nov 29, 2012 05:33 PM EST

FDA approves Exelixis' cabozantinib for thyroid cancer reuters.com Thu, 29 Nov, 2012 02:10 PM PST WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday approved Exelixis Inc's cabozantinib as a treatment for medullary thyroid cancer that has spread to other parts of the body. Cabozantinib, the company's lead product candidate, is an oral drug designed to limit blood supply to tumors as well as block two segments of a pathway used by cancer cells to grow and spread. The FDA ...

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of persona l information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.